Labshake search
Citations for BioLegend :
1 - 50 of 1039 citations for NKX2 4 Blocking Peptide since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Immunology 2019Quote: Samples were incubated overnight at 4°C in primary antibody diluted in blocking buffer (Biolegend 103101 rat anti-CD45 ...
-
bioRxiv - Cancer Biology 2023Quote: ... USA) cells were incubated with anti-PD-L1 blocking antibody (Ab; 4 μg/mL; BioLegend #29702 ...
-
bioRxiv - Cell Biology 2019Quote: ... cells were then incubated for 10 minutes at 4°C in human Fc Blocking reagent (FcX, BioLegend). Cells were incubated at 4°C for a further 30 minutes with 0.5µg of TotalSeq™-A (Biolegend ...
-
bioRxiv - Bioengineering 2021Quote: ... which were incubated overnight at 4 °C with primary antibodies diluted 1:5,000 in blocking buffer (BioLegend Way ...
-
bioRxiv - Cell Biology 2021Quote: ... cells were then incubated for 10 minutes at 4°C in human Fc Blocking reagent (FcX, BioLegend). Cells were incubated at 4°C for a further 30 minutes with 0.5μg of TotalSeq-A (Biolegend ...
-
bioRxiv - Cell Biology 2021Quote: ... were blocked with 5ul Human TruStain FcX™ Blocking Reagent for 10 minutes at 4°C (BioLegend). 1ug of each TotalSeq™-A antibody was added to the cell suspension ...
-
bioRxiv - Immunology 2024Quote: ... Staining with primary antibodies was performed overnight at 4°C in blocking buffer (LN: IgD (Biolegend, 405705), and CD8 (Abcam ...
-
bioRxiv - Systems Biology 2019Quote: ... FcX blocking solution (BioLegend) was added in a dilution of 1:50.
-
bioRxiv - Cell Biology 2020Quote: ... FcX blocking solution (BioLegend) was added at a dilution of 1:50.
-
bioRxiv - Immunology 2021Quote: Monocyte blocking solution (BioLegend) and Brilliant Stain Buffer (BD ...
-
bioRxiv - Immunology 2020Quote: ... stained for 20 min at 4 °C in PBS/2% FCS in presence of Fc receptor blocking reagent (Biolegend) with anti-murine CD326-BV605 ...
-
bioRxiv - Immunology 2019Quote: ... Primary antibody labeling was performed in blocking buffer overnight at 4°C in a humidified chamber using the following antibodies: anti-CD4 Alexa Fluor 647 (BioLegend), goat anti-IgD purified (Cedarlane Labs) ...
-
bioRxiv - Immunology 2021Quote: ... cells were blocked for 1 hour at 37⁰C with 300µl of Duolink® blocking solution then stained overnight at 4⁰C with purified mouse anti-Phosphoserine (Biolegend) or purified mouse IgG1 isotype control (clone MG1-45 ...
-
bioRxiv - Neuroscience 2022Quote: ... Sections were then incubated overnight at 4°C with primary antibodies diluted in blocking solution: anti-βIII Tubulin (1/500, Biolegend), anti-RSK2 (1/100 ...
-
bioRxiv - Genetics 2023Quote: ... Primary antibody staining was carried out at 4°C overnight with the following antibody dilutions in blocking buffer: CD52-APC (clone HI186, BioLegend) 1:200 ...
-
bioRxiv - Immunology 2021Quote: ... Fc-blocking reagent (Biolegend, 422301) was used to block Fc receptor-introduced non-specific staining ...
-
bioRxiv - Genomics 2024Quote: ... Fc-blocking reagent (BioLegend, 422301) was used to block Fc receptor-introduced nonspecific staining ...
-
bioRxiv - Cell Biology 2020Quote: ... Slides were incubated with the following primary antibodies diluted in blocking buffer overnight at 4°C – chicken anti-keratin 14 (1:800, Biolegend 906001), rabbit anti-SCD1 (1:500 ...
-
bioRxiv - Microbiology 2020Quote: Splenocytes from intramuscularly vaccinated mice were incubated in culture with a pool of 253 overlapping 15-mer SARS-CoV-2 S peptides (Grifoni et al., 2020) for 12 h at 37°C before a 4 h treatment with brefeldin A (BioLegend, 420601). Following blocking with FcγR antibody (BioLegend ...
-
bioRxiv - Microbiology 2023Quote: Splenocytes from intramuscularly vaccinated mice were incubated in culture with a pool of 253 overlapping 15-mer SARS-CoV-2 S peptides(25) for 12 h at 37°C before a 4 h treatment with brefeldin A (BioLegend, 420601). Following blocking with an anti-FcψR antibody (BioLegend ...
-
bioRxiv - Systems Biology 2021Quote: Cells were stained overnight at 4°C in blocking solution with the following antibodies: AlexaFluor® 488 anti-Vimentin (1:1000, Biolegend, #677809), AlexaFluor® E-cadherin (1:200 ...
-
bioRxiv - Developmental Biology 2019Quote: ... Cells were then incubated overnight at 4°C with primary antibody diluted in blocking solution (rabbit anti-FLAG, Sigma, 1:250 or mouse anti-Tuj1, Biolegend 1:500). After washing in PBS and incubation with secondary antibody (Alexa 647 anti-goat IgG 1:500 ...
-
bioRxiv - Immunology 2021Quote: 4*106 peripheral blood mononuclear cells (PBMCs) per patient were first incubated with Human TruStain FcX™ blocking reagent (Biolegend, Cat# 422302) for 10 minutes at 4°C ...
-
bioRxiv - Immunology 2022Quote: ... Cells were incubated with Fixable Viability Stain 510 for 15 minutes at 4 °C followed by anti-Fc blocking reagent (Biolegend, Cat# 101320) for 10 minutes prior to surface staining ...
-
bioRxiv - Immunology 2023Quote: ... Sections were stained using a three-colour protocol with 1:100 of each of the following antibodies in IF blocking buffer at 4 °C O/N: Alexa Fluor 488® anti-mouse GL-7 (GL-7; Biolegend, #144612), PE anti-mouse CD3 (145-2C11 ...
-
bioRxiv - Cell Biology 2023Quote: ... Slides were incubated with antibody cocktails in blocking buffer overnight at 4°C in a moisture chamber: Amyloid-β (6E10) (1:100; Biolegend, 803001), anti-CHMP2B (1:100 ...
-
bioRxiv - Cancer Biology 2021Quote: ... blocked with FcX blocking buffer (BioLegend) for 10 minutes on ice and then incubated with hash-antibodies (TotalSeq from BioLegend ...
-
bioRxiv - Immunology 2020Quote: ... CD112 blocking antibody (clone TX31, Biolegend), 10 μM LY2109761 ...
-
bioRxiv - Immunology 2020Quote: ... CD44 blocking antibody (clone IM7, Biolegend), ILT-2 (CD85J ...
-
bioRxiv - Cancer Biology 2019Quote: ... and Fc receptor blocking solution (Biolegend), before staining with fluorochrome-conjugated anti-human antibodies specific to anti-CD3 (UCHT1)/anti-CD45 (2D1) ...
-
bioRxiv - Neuroscience 2022Quote: ... After fragment crystallizable (Fc) blocking (Biolegend), cells were stained for surface antigens (Extended Data Table 4) ...
-
bioRxiv - Immunology 2020Quote: ... CD25 blocking antibodies (Clone 3C7, BioLegend) were added to culture media prior to T cell stimulation ...
-
bioRxiv - Immunology 2023Quote: ... blocked with FcR blocking reagent (BioLegend) on ice for 10 min and then incubated with surface antibody cocktail for 30 min in dark ...
-
bioRxiv - Immunology 2023Quote: ... underwent blocking in TruStainFcX (Biolegend, 422302) for 10 min and were stained with a mixture of EPCAM (anti-CD326 PE ...
-
bioRxiv - Cancer Biology 2023Quote: ... performed with Fc blocking (422302, BioLegend), and labelled with anti-CD138 (142508 ...
-
bioRxiv - Immunology 2023Quote: ... DQ blocking antibody (Biolegend, Cat# 361702) were included to confirm MHC dependent IFNγ release.
-
bioRxiv - Immunology 2023Quote: ... After Fc blocking (TruStain FcX; BioLegend), cells were stained with a metal-conjugated surface antibody cocktail (Table 2) ...
-
bioRxiv - Immunology 2021Quote: ... 20 µL diluted peptide and 20µL 1µg/mL UV-sensitive peptide HLA-A2 monomer (BioLegend) were added into 96-well plates and mixed well by pipetting up and down ...
-
bioRxiv - Genomics 2021Quote: ... Sections were incubated with the following primary antibodies at the indicated dilution in blocking buffer overnight at 4°C: NeuN (BioLegend 1B7, cat #834502), p65 (BioLegend Poly6226 ...
-
bioRxiv - Cancer Biology 2023Quote: ... and stained overnight at 4°C in blocking solution with the following primary antibodies and dilutions: anti-Nestin (1:150, Biolegend, #656802, clone 10C2), anti-EGFR (1:300 ...
-
bioRxiv - Immunology 2021Quote: ... VEGFA blocking antibody (BioLegend, 2G11-2A05, 50μg) was administered intravenous ...
-
bioRxiv - Immunology 2020Quote: ... Fc receptor blocking antibody (CD16/CD32; Biolegend), anti-EpCAM (clone G8.8 ...
-
bioRxiv - Immunology 2022Quote: ... Fc receptor-blocking antibody (CD16/CD32; BioLegend), anti-EpCAM (clone G8.8 ...
-
bioRxiv - Immunology 2020Quote: ... Pre-blocking step with TruStain FcX (BioLegend) was included for all staining ...
-
bioRxiv - Immunology 2022Quote: ... 10 µl TruStain FcX blocking reagent (BioLegend) was added ...
-
bioRxiv - Immunology 2022Quote: After Fc-blocking using FcX reagents (BioLegend), cells were incubated with primary antibodies in FACS buffer for 30 min at 4°C and if necessary ...
-
bioRxiv - Genomics 2022Quote: ... FcX blocking solution (BioLegend catalogue no. 101319) was added at a dilution of 1:50 ...
-
bioRxiv - Systems Biology 2022Quote: ... Human TruStain FcX FC blocking reagent (BioLegend) was added according to manufacturers’ instructions for 10min on ice ...
-
bioRxiv - Immunology 2023Quote: ... blocking antibodies to TNFa (MAb-1, Biolegend) were added at a concentration of 1 ug/mL ...
-
bioRxiv - Immunology 2023Quote: ... HLA-ABC blocking antibody (Biolegend, Cat# 311428) and HLA-DR ...